Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
363 | 3 | RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN II//BRADYKININ | 35741 |
2089 | 2 | HEREDITARY ANGIOEDEMA//ANGIOEDEMA//C1 INHIBITOR | 5570 |
824 | 1 | MOEXIPRIL//QUINAPRIL//CAS 89396 94 1 | 3066 |
3350 | 1 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA | 2038 |
24978 | 1 | IMIDAPRIL//IMIDAPRIL HYDROCHLORIDE//IMIDAPRILAT | 318 |
32667 | 1 | TRANDOLAPRIL//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY//VERAPAMIL TRANDOLAPRIL | 148 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | HEREDITARY ANGIOEDEMA | authKW | 2026716 | 7% | 94% | 380 |
2 | ANGIOEDEMA | authKW | 930136 | 6% | 53% | 311 |
3 | C1 INHIBITOR | authKW | 902508 | 4% | 76% | 211 |
4 | C1 INHIBITOR DEFICIENCY | authKW | 454074 | 2% | 94% | 85 |
5 | C1 ESTERASE INHIBITOR | authKW | 289077 | 1% | 67% | 76 |
6 | ACQUIRED ANGIOEDEMA | authKW | 237695 | 1% | 98% | 43 |
7 | ICATIBANT | authKW | 221669 | 1% | 56% | 70 |
8 | ECALLANTIDE | authKW | 192318 | 1% | 100% | 34 |
9 | HAE | authKW | 178789 | 1% | 88% | 36 |
10 | C1 INH | authKW | 164742 | 1% | 79% | 37 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Allergy | 21430 | 9% | 1% | 517 |
2 | Pharmacology & Pharmacy | 16161 | 32% | 0% | 1806 |
3 | Cardiac & Cardiovascular System | 8359 | 16% | 0% | 899 |
4 | Medicine, General & Internal | 4834 | 15% | 0% | 827 |
5 | Peripheral Vascular Diseases | 4509 | 9% | 0% | 499 |
6 | Immunology | 2082 | 11% | 0% | 605 |
7 | Medicine, Research & Experimental | 985 | 6% | 0% | 343 |
8 | Dermatology | 280 | 2% | 0% | 124 |
9 | Chemistry, Medicinal | 203 | 3% | 0% | 144 |
10 | Emergency Medicine | 184 | 1% | 0% | 53 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | REFERENCE ANGIOEDEMA | 107472 | 0% | 100% | 19 |
2 | ANGIOEDEMA | 73533 | 0% | 100% | 13 |
3 | HUNGARIAN ANGIOEDEMA | 68279 | 0% | 93% | 13 |
4 | MU CTY HOSP | 65210 | 0% | 82% | 14 |
5 | HAE DENMARK | 50908 | 0% | 100% | 9 |
6 | REFERENCE ANGIOEDEMES CREAK | 50908 | 0% | 100% | 9 |
7 | BIOMED NETWORK RARE DIS CIBERER U754 | 39595 | 0% | 100% | 7 |
8 | CLIN UNIV MED INTERNE | 37013 | 0% | 55% | 12 |
9 | GREPI AGIM CNRS FRE 3405 | 29088 | 0% | 86% | 6 |
10 | ALLERGOL ANGIOEDEMA OUTPATIENT CLIN | 28282 | 0% | 100% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 29465 | 4% | 2% | 241 |
2 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 24818 | 3% | 2% | 191 |
3 | ALLERGY AND ASTHMA PROCEEDINGS | 20504 | 1% | 5% | 77 |
4 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 19555 | 1% | 5% | 69 |
5 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 15180 | 2% | 2% | 114 |
6 | ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 8798 | 1% | 2% | 77 |
7 | JOURNAL OF HYPERTENSION | 8278 | 2% | 1% | 121 |
8 | IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 6519 | 1% | 3% | 40 |
9 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 5439 | 2% | 1% | 84 |
10 | AMERICAN JOURNAL OF CARDIOLOGY | 5193 | 3% | 1% | 161 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEREDITARY ANGIOEDEMA | 2026716 | 7% | 94% | 380 | Search HEREDITARY+ANGIOEDEMA | Search HEREDITARY+ANGIOEDEMA |
2 | ANGIOEDEMA | 930136 | 6% | 53% | 311 | Search ANGIOEDEMA | Search ANGIOEDEMA |
3 | C1 INHIBITOR | 902508 | 4% | 76% | 211 | Search C1+INHIBITOR | Search C1+INHIBITOR |
4 | C1 INHIBITOR DEFICIENCY | 454074 | 2% | 94% | 85 | Search C1+INHIBITOR+DEFICIENCY | Search C1+INHIBITOR+DEFICIENCY |
5 | C1 ESTERASE INHIBITOR | 289077 | 1% | 67% | 76 | Search C1+ESTERASE+INHIBITOR | Search C1+ESTERASE+INHIBITOR |
6 | ACQUIRED ANGIOEDEMA | 237695 | 1% | 98% | 43 | Search ACQUIRED+ANGIOEDEMA | Search ACQUIRED+ANGIOEDEMA |
7 | ICATIBANT | 221669 | 1% | 56% | 70 | Search ICATIBANT | Search ICATIBANT |
8 | ECALLANTIDE | 192318 | 1% | 100% | 34 | Search ECALLANTIDE | Search ECALLANTIDE |
9 | HAE | 178789 | 1% | 88% | 36 | Search HAE | Search HAE |
10 | C1 INH | 164742 | 1% | 79% | 37 | Search C1+INH | Search C1+INH |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |